NewEdge Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $681K | Buy |
|
|||||
|
2025
Q2 | $417K | Buy |
|
|||||
|
2025
Q1 | $115K | Sell |
|
|||||
|
2024
Q4 | $292K | Buy |
|
|||||
|
2024
Q3 | $272K | Sell |
|
|||||
|
2024
Q2 | $514K | Buy |
|
|||||
|
2024
Q1 | $619K | Buy |
|
|||||
|
2023
Q4 | $123K | Buy |
|
|||||
|
2023
Q3 | $59.4K | Sell |
|
|||||
|
2023
Q2 | $75.2K | Sell |
|
|||||
|
2023
Q1 | $92K | Sell |
|
|||||
|
2022
Q4 | $405K | Sell |
|
|||||
|
2022
Q3 | $989K | Buy |
|